E-Therapeutics was founded in 2003 and is headquartered in Long Hanborough, GB

E-Therapeutics has an office in Long Hanborough

Long Hanborough, GB (HQ)

Blenheim Office Park, 17 Fenlock Rd

E-Therapeutics's revenue was reported to be £67 k in FY, 2009 which is a **5% increase** from the previous period.

GBP

## Net income (FY, 2017) | (13.1 m) |

## EBITDA (FY, 2017) | (16.3 m) |

## EBIT (FY, 2017) | (16.3 m) |

## Market capitalization (20-Oct-2017) | 28.5 m |

## Closing share price (20-Oct-2017) | 0.1 |

## Cash (31-Jan-2017) | 14 m |

E-Therapeutics's current market capitalization is £28.5 m.

- Source: Company Filings

GBP | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|---|---|---|---|---|

## Net Income | (2 m) | (1.5 m) | (1.8 m) | (2.3 m) | (3.2 m) | (4.2 m) | (5 m) | (7.8 m) | (8.8 m) | (13.1 m) |

## Cash From Operating Activities | (2.2 m) | (1.5 m) | (1.7 m) | (1.9 m) | (3.2 m) | (4.2 m) | (5.7 m) | (9.9 m) | (9.2 m) | (9.4 m) |

## Cash From Financing Activities | 4.1 m | 4.4 m | 82 k | 16.4 m | 15 k | 39 m | 77 k | 12 k | 13 k | |

## Net Change in Cash | 1.8 m | (1.6 m) | 2.5 m | (2 m) | 5.2 m | (1.9 m) | 2.7 m | (5.1 m) | 4.5 m | (1.9 m) |

Y, 2017 | |
---|---|

## Financial Leverage | 1.1 x |

E-Therapeutics's Projects Launched was reported to be 12 in FY, 2016, which is a 100% increase from the previous period

FY, 2015 | FY, 2016 | |
---|---|---|

## Projects Launched | 6 | 12 |